Physician profile
Jon E Derksen
NPI 1649254905
$8,787.18
in general payments reported to CMS, 2019-2025
47 companies · $765 in 2025
The $765 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,078 · 2020: $315 · 2021: $1,005 · 2022: $1,435 · 2023: $3,130 · 2024: $1,058 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,828 · Travel and Lodging: $1,050 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,828.09 |
| Travel and Lodging | $1,050.30 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,186.81 | 2023-2025 | Nanoknife |
| Astellas Pharma US INC | $1,300.34 | 2019-2025 | Xtandi |
| Abbvie INC. | $622.38 | 2020-2025 | Botox, Lupron Depot |
| Pfizer INC. | $605.12 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $380.68 | 2019-2024 | Xiaflex, Aveed, Edex |
| Boston Scientific Corporation | $367.00 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Lithovue |
| Rochester Medical Corporation | $346.32 | 2020-2022 | |
| Janssen Biotech, INC. | $331.62 | 2019-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $236.40 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $217.52 | 2022-2025 | Pylarify |
| Dendreon Pharmaceuticals LLC | $200.90 | 2019-2023 | Provenge |
| Merck Sharp & Dohme LLC | $167.24 | 2020-2025 | Welireg, Keytruda, Zerbaxa |
| Philips North America LLC | $121.71 | 2022 | |
| Novartis Pharmaceuticals Corporation | $112.60 | 2019-2025 | |
| Amgen INC. | $102.21 | 2019-2021 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Derksen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.